Biomedical data might hold the key to finding the cure for currently incurable diseases. Our mission is to reduce the complexity of RNA-seq data into plausible candidates for drug and biomarker development. Our Software as a service (SaaS) to extract biologically relevant RNA isoforms from raw RNA-seq data. Discover new drug targets and biomarkers through splice isoform quantification coupled with predictive-analytics. Prioritize disease-related genes connecting your data to our databases and algorithms. Rapidly advance to experimental validation with a well supported list of targets.
Huntington, US
4 (est)

Envisagenics Locations

Huntington, US

Envisagenics Metrics

Envisagenics Summary

Founding Date


Total Funding

$225 K

Latest funding size

$225 K

Time since last funding

about 1 year